Skip to main content
22 May 2024

Immune ‘brake’ reveals drug targets for cancer and autoimmune disease

Researchers have identified a new genomic signature that controls whether the immune system’s specialised ‘killer’ T cells activate or stand down, revealing 100 potential new drug targets for cancer and autoimmune disease.

Read article